Skip to main content
. 2021 Mar 26;23(3):e24366. doi: 10.2196/24366

Table 4.

Mixed model estimated means for the outcomes in both groups and within-group effect sizes.

Outcome T0 baseline (95% CI) T1 posttreatment (95% CI) T2 6-month follow-up (95% CI) T3 12-month follow-up (95% CI) ESa T0-T1 ES T1-T2 ES T1-T3
GAD-7b

Blended ACTc 8.18 (7.49-8.88) 4.35 (3.59-5.12) 4.67 (3.86-5.49) 3.96 (3.09-4.83) 0.96 0.10 0.11

CBTd 8.78 (8.12-9.44) 4.76 (4.06-5.47) 5.72 (4.99-6.45) 4.70 (3.89-5.50) 1.09 0.28 0.02
MHC-SFe

Blended ACT 2.73 (2.54-2.91) 2.96 (2.75-3.17) 2.98 (2.76-3.19) 3.04 (2.82-3.26) 0.24 0.02 0.09

CBT 2.57 (2.40-2.74) 2.92 (2.73-3.12) 2.91 (2.72-3.10) 2.73 (2.52-2.94) 0.38 0.01 0.20
PHQ-9f

Blended ACT 6.99 (6.28-7.71) 4.14 (3.30-5.00) 3.16 (2.35-3.97) 3.19 (2.3-4.06) 0.70 0.26 0.27

CBT 7.92 (7.24-8.60) 4.76 (3.97-5.55) 4.44 (3.71-5.18) 4.33 (3.52-5.14) 0.75 0.08 0.12
SDSg work

Blended ACT 3.52 (2.94-4.11) 1.80 (1.16-2.44) N/Ah 1.94 (1.17-2.71) 0.67 N/A 0.06

CBT 3.76 (3.17-4.35) 1.75 (1.17-2.34) N/A 1.25 (0.45-2.05) 0.82 N/A 0.24
SDS social life

Blended ACT 4.02 (3.51-4.53) 2.16 (1.57-2.74) N/A 2.05 (1.38-2.72) 0.75 N/A 0.04

CBT 4.08 (3.59-4.56) 2.39 (1.86-2.91) N/A 2.20 (1.53-2.86) 0.63 N/A 0.07
SDS family and/or home

Blended ACT 3.82 (3.30-4.33) 1.90 (1.34-2.45) N/A 1.54 (0.84-2.23) 0.76 N/A 0.16

CBT 3.79 (3.30-4.28) 1.85 (1.35-2.35) N/A 1.87 (1.19-2.55) 0.71 N/A 0.00
MINIi-plusj

Blended ACT 0 0.10 (0.02-0.30) N/A 0.09 (0.03-0.21) N/A N/A N/A

CBT 0 0.02 (0.00-0.17) N/A 0.08 (0.03-0.19) N/A N/A N/A
MINI-plusk

Blended ACT 1 0.28 (0.14-0.46) N/A 0.08 (0.02-0.28) N/A N/A N/A

CBT 1 0.21 (0.10-0.39) N/A 0.20 (0.05-0.54) N/A N/A N/A

aES: effect size.

bGAD-7: Generalized Anxiety Disorder-7.

cACT: acceptance and commitment therapy.

dCBT: cognitive behavioral therapy.

eMHC-SF: Mental Health Continuum-Short Form.

fPHQ-9: Patient Health Questionnaire-9.

gSDS: Sheehan Disability Scale.

hN/A: not applicable.

iMINI: Mini-International Neuropsychiatric Interview.

jProbabilities of having an anxiety disorder for participants without anxiety disorder at baseline (n=233).

kProbabilities of having an anxiety disorder for participants with anxiety disorder at baseline (n=81).